New Key Statistics Module, Z-Score and F-Score
OTCPK:JWCTF Key Ratios
| Market Cap $ M | 120.00 |
| Enterprise Value $ M | 25.92 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.57 |
| Price/Sales | 5.68 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 23.00 |
| EPS (TTM) $ | -0.26 |
| Beneish M-Score | -3.78 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -6.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.36 |
| EV-to-EBITDA | -0.37 |
| PEG | -- |
| Shares Outstanding M | 414.36 |
| Net Margin (%) | -476.65 |
| Operating Margin % | -397.09 |
| Pre-tax Margin (%) | -476.65 |
| Quick Ratio | 3.90 |
| Current Ratio | 4.04 |
| ROA % (ttm) | -31.62 |
| ROE % (ttm) | -38.83 |
| ROIC % (ttm) | -46.06 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.62 |
JWCTF Number of Guru Trades
JWCTF Volume of Guru Trades
Gurus Latest Trades with OTCPK:JWCTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:JWCTF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
JW (Cayman) Therapeutics Co Ltd Insider Transactions
No Available Data
News about OTCPK:JWCTF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers